Janssen-Cilag International NV
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference ab88d7f6cb
Drug names40First applicant · distinct drug namesAcceptance records325First applicant · distinct acceptance numbersUnder-review numbers36First applicant · current under-review listCo-applicant records28Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
325 acceptance records as first applicant, grouped into 40 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
No verified English name 27 records · Latest accepted 2026/11/05
Supplement · 25Import re-registration · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600311 | Supplement | 2026/11/05 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2600310 | Supplement | 2026/11/05 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2600261 | Supplement | 2026/09/22 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2500196 | Supplement | 2025/08/23 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2500195 | Supplement | 2025/08/23 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2500194 | Supplement | 2025/08/23 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2500127 | Supplement | 2025/05/31 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2500126 | Supplement | 2025/05/31 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2500125 | Supplement | 2025/05/31 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2500093 | Supplement | 2025/04/03 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2500092 | Supplement | 2025/04/03 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2400229 | Supplement | 2024/10/17 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2400228 | Supplement | 2024/10/17 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2300220 | Supplement | 2023/12/20 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSZ2300031 | Import re-registration | 2023/07/25 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYSZ2300030 | Import re-registration | 2023/07/25 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYSB2300044 | Supplement | 2023/03/07 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2300043 | Supplement | 2023/03/07 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2200172 | Supplement | 2022/09/04 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2200132 | Supplement | 2022/07/20 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2200131 | Supplement | 2022/07/20 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2200102 | Supplement | 2022/06/20 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2200101 | Supplement | 2022/06/20 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2200098 | Supplement | 2022/06/16 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2200097 | Supplement | 2022/06/16 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2101093 | Supplement | 2021/07/27 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2101092 | Supplement | 2021/07/27 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/10/23
Supplement · 2
Ibrutinib Capsules 13 records · Latest accepted 2026/10/21
Supplement · 10Import re-registration · 2Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600561 | Supplement | 2026/10/21 | Janssen-Cilag International NV; Catalent CTS LLC; Cilag AG | CDE ↗ |
| JYHZ2600188 | Import re-registration | 2026/08/05 | Janssen-Cilag International NV; Catalent CTS LLC; Cilag AG; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2600055 | Supplement | 2026/01/23 | Janssen-Cilag International NV; Catalent CTS LLC | CDE ↗ |
| JYHB2400638 | Supplement | 2024/12/12 | Janssen-Cilag International NV; Catalent CTS LLC | CDE ↗ |
| JYHB2400574 | Supplement | 2024/10/28 | Janssen-Cilag International NV; Catalent CTS LLC | CDE ↗ |
| JYHB2400150 | Supplement | 2024/04/08 | Janssen-Cilag International NV; Catalent CTS LLC; Cilag AG | CDE ↗ |
| JYHB2200549 | Supplement | 2022/10/12 | Janssen-Cilag International NV; Catalent CTS LLC | CDE ↗ |
| JYHB2200458 | Supplement | 2022/08/19 | Janssen-Cilag International NV; Catalent CTS LLC | CDE ↗ |
| JXHS2200052 | Import | 2022/05/31 | Janssen-Cilag International NV; Catalent CTS LLC; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2200236 | Supplement | 2022/04/24 | Janssen-Cilag International NV; Catalent CTS LLC | CDE ↗ |
| JYHB2101476 | Supplement | 2021/10/21 | Janssen-Cilag International NV; Catalent CTS LLC | CDE ↗ |
| JYHZ2100646 | Import re-registration | 2021/10/09 | Janssen-Cilag International NV; Catalent CTS LLC; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2100105 | Supplement | 2021/02/02 | Janssen-Cilag International NV; Catalent CTS LLC | CDE ↗ |
Canagliflozin Tablets 16 records · Latest accepted 2026/10/21
Supplement · 14Import re-registration · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600564 | Supplement | 2026/10/21 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHB2600563 | Supplement | 2026/10/21 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHB2500363 | Supplement | 2025/07/10 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHB2500362 | Supplement | 2025/07/10 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHB2400616 | Supplement | 2024/11/28 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHB2400615 | Supplement | 2024/11/28 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHZ2400275 | Import re-registration | 2024/10/12 | Janssen-Cilag International NV; Janssen-Cilag S.p.A.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2400274 | Import re-registration | 2024/10/12 | Janssen-Cilag International NV; Janssen-Cilag S.p.A.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2300622 | Supplement | 2023/11/01 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHB2300621 | Supplement | 2023/11/01 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHB2300185 | Supplement | 2023/03/21 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHB2300184 | Supplement | 2023/03/21 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHB2200296 | Supplement | 2022/06/14 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHB2200295 | Supplement | 2022/06/14 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHB2101050 | Supplement | 2021/04/16 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHB2101049 | Supplement | 2021/04/16 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
No verified English name 6 records · Latest accepted 2026/10/19
Import · 4Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSS2600097 | Import | 2026/10/19 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXSS2600096 | Import | 2026/10/19 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JYSB2500136 | Supplement | 2025/06/17 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2500135 | Supplement | 2025/06/17 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC | CDE ↗ |
| JXSS2400012 | Import | 2024/02/08 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXSS2400011 | Import | 2024/02/08 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
Bortezomib For Injection 3 records · Latest accepted 2026/10/16
Import re-registration · 1Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600266 | Import re-registration | 2026/10/16 | Janssen-Cilag International NV; BSP Pharmaceuticals S.p.A.; XIAN JANSSEN PHARMACEUTICAL Ltd. | CDE ↗ |
| JYHB2400468 | Supplement | 2024/08/30 | Janssen-Cilag International NV; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JYHB2400033 | Supplement | 2024/01/23 | Janssen-Cilag International NV; BSP Pharmaceuticals S.p.A. | CDE ↗ |
Apalutamide Tablets 13 records · Latest accepted 2026/09/22
Supplement · 11Import · 1Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600530 | Supplement | 2026/09/22 | Janssen-Cilag International NV; Janssen Ortho LLC; Catalent Pharma Solutions LLC | CDE ↗ |
| JXHS2600061 | Import | 2026/06/10 | Janssen-Cilag International NV; Janssen Ortho LLC; Catalent Pharma Solutions LLC; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2500062 | Supplement | 2025/02/08 | Janssen-Cilag International NV; Janssen Ortho LLC; Catalent Pharma Solutions LLC | CDE ↗ |
| JYHB2400544 | Supplement | 2024/10/13 | Janssen-Cilag International NV; Janssen Ortho LLC; Catalent Pharma Solutions LLC | CDE ↗ |
| JYHB2400175 | Supplement | 2024/04/23 | Janssen-Cilag International NV; Janssen Ortho LLC | CDE ↗ |
| JYHZ2400051 | Import re-registration | 2024/02/28 | Janssen-Cilag International NV; Janssen Ortho LLC; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2300745 | Supplement | 2023/12/26 | Janssen-Cilag International NV; Janssen Ortho LLC | CDE ↗ |
| JYHB2300569 | Supplement | 2023/10/11 | Janssen-Cilag International NV; 1. Catalent Pharma Solutions LLC; 2. Janssen Ortho LLC | CDE ↗ |
| JYHB2300568 | Supplement | 2023/10/10 | Janssen-Cilag International NV; Janssen Ortho LLC | CDE ↗ |
| JYHB2300128 | Supplement | 2023/02/17 | Janssen-Cilag International NV; Janssen Ortho LLC | CDE ↗ |
| JYHB2300075 | Supplement | 2023/01/31 | Janssen-Cilag International NV; Janssen Ortho LLC | CDE ↗ |
| JYHB2200003 | Supplement | 2022/01/06 | Janssen-Cilag International NV; Janssen Ortho LLC | CDE ↗ |
| JYHB2100139 | Supplement | 2021/02/11 | Janssen-Cilag International NV; Janssen Ortho LLC | CDE ↗ |
Selexipag Tablets 18 records · Latest accepted 2026/09/20
Import · 10Supplement · 8
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHS2600113 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXHS2600112 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXHS2600111 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXHS2600110 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXHS2600109 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXHS2600108 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXHS2600107 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXHS2600106 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXHS2600092 | Import | 2026/08/17 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXHS2600091 | Import | 2026/08/17 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JYHB2600013 | Supplement | 2026/01/05 | Janssen-Cilag International NV; Excella GmbH & Co. KG | CDE ↗ |
| JYHB2600012 | Supplement | 2026/01/05 | Janssen-Cilag International NV; Excella GmbH & Co. KG | CDE ↗ |
| JYHB2600011 | Supplement | 2026/01/05 | Janssen-Cilag International NV; Excella GmbH & Co. KG | CDE ↗ |
| JYHB2600010 | Supplement | 2026/01/05 | Janssen-Cilag International NV; Excella GmbH & Co. KG | CDE ↗ |
| JYHB2600009 | Supplement | 2026/01/05 | Janssen-Cilag International NV; Excella GmbH & Co. KG | CDE ↗ |
| JYHB2600008 | Supplement | 2026/01/05 | Janssen-Cilag International NV; Excella GmbH & Co. KG | CDE ↗ |
| JYHB2600007 | Supplement | 2026/01/05 | Janssen-Cilag International NV; Excella GmbH & Co. KG | CDE ↗ |
| JYHB2600006 | Supplement | 2026/01/05 | Janssen-Cilag International NV; Excella GmbH & Co. KG | CDE ↗ |
No verified English name 28 records · Latest accepted 2026/06/25
Supplement · 16Import · 10Import re-registration · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600184 | Supplement | 2026/06/25 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2600183 | Supplement | 2026/06/25 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JXSS2600037 | Import | 2026/04/16 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXSS2600036 | Import | 2026/04/16 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXSL2500206 | Import | 2025/10/18 | Janssen-Cilag International NV; Johnson & Johnson (China) Investment Ltd. | CDE ↗ |
| JXSS2500022 | Import | 2025/03/06 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXSS2400104 | Import | 2024/11/27 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYSB2400221 | Supplement | 2024/10/10 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JXSS2400053 | Import | 2024/07/03 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXSS2400052 | Import | 2024/07/03 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYSZ2400022 | Import re-registration | 2024/05/06 | Janssen-Cilag International NV; Cilag AG; XIAN JANSSEN PHARMACEUTICAL LTD. | CDE ↗ |
| JYSZ2400021 | Import re-registration | 2024/05/06 | Janssen-Cilag International NV; Cilag AG; XIAN JANSSEN PHARMACEUTICAL LTD. | CDE ↗ |
| JYSB2400085 | Supplement | 2024/04/20 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JXSS2400028 | Import | 2024/03/27 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXSS2400027 | Import | 2024/03/27 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYSB2300014 | Supplement | 2023/01/31 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2300013 | Supplement | 2023/01/31 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2300011 | Supplement | 2023/01/17 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2300010 | Supplement | 2023/01/17 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2200211 | Supplement | 2022/11/15 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JXSL2200163 | Import | 2022/09/09 | Janssen-Cilag International NV; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYSB2101189 | Supplement | 2021/12/09 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2101188 | Supplement | 2021/12/09 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2101133 | Supplement | 2021/09/13 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2101024 | Supplement | 2021/05/14 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2100074 | Supplement | 2021/03/12 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2100003 | Supplement | 2021/01/07 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2100002 | Supplement | 2021/01/07 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
No verified English name 10 records · Latest accepted 2026/06/24
Supplement · 6Import · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600182 | Supplement | 2026/06/24 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2600181 | Supplement | 2026/06/24 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC | CDE ↗ |
| JXSS2600039 | Import | 2026/04/17 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXSS2600038 | Import | 2026/04/17 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JYSB2500220 | Supplement | 2025/09/16 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2500219 | Supplement | 2025/09/16 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2400210 | Supplement | 2024/09/25 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC | CDE ↗ |
| JYSB2400209 | Supplement | 2024/09/25 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC | CDE ↗ |
| JXSS2300070 | Import | 2023/08/19 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXSS2300069 | Import | 2023/08/19 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2026/06/23
Supplement · 1Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600174 | Supplement | 2026/06/23 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JXSS2400054 | Import | 2024/07/03 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXSS2400029 | Import | 2024/03/27 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
No verified English name 4 records · Latest accepted 2026/06/10
Supplement · 2Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600317 | Supplement | 2026/06/10 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JYHB2500458 | Supplement | 2025/08/27 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| JXHS2400076 | Import | 2024/10/11 | Janssen-Cilag International NV; JANSSEN CILAG S.P.A.; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXHS2400009 | Import | 2024/01/26 | Janssen-Cilag International NV; JANSSEN CILAG S.P.A.; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
Miglustat Capsules 6 records · Latest accepted 2026/06/08
Import re-registration · 2Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600139 | Import re-registration | 2026/06/08 | Janssen-Cilag International NV; Almac Pharma Services Limited; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JYHB2400011 | Supplement | 2024/01/10 | Janssen-Cilag International NV; Almac Pharma Services Limited | CDE ↗ |
| JYHB2300270 | Supplement | 2023/04/26 | Janssen-Cilag International NV; Almac Pharma Services Limited | CDE ↗ |
| JYHB2200173 | Supplement | 2022/04/01 | Janssen-Cilag International NV; Almac Pharma Services Limited | CDE ↗ |
| JYHZ2100534 | Import re-registration | 2021/04/30 | Janssen-Cilag International NV; Almac Pharma Services Limited; Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JYHB2100062 | Supplement | 2021/01/16 | Janssen-Cilag International NV; Almac Pharma Services Limited | CDE ↗ |
No verified English name 4 records · Latest accepted 2026/06/01
Import · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSS2600045 | Import | 2026/06/01 | Janssen-Cilag International NV; Vetter Pharma-Fertigung GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXSS2600044 | Import | 2026/06/01 | Janssen-Cilag International NV; Vetter Pharma-Fertigung GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXSS2500050 | Import | 2025/04/23 | Janssen-Cilag International NV; Vetter Pharma-Fertigung GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXSS2500049 | Import | 2025/04/23 | Janssen-Cilag International NV; Vetter Pharma-Fertigung GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
No verified English name 12 records · Latest accepted 2026/05/14
Supplement · 4Import · 8
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600125 | Supplement | 2026/05/14 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2600124 | Supplement | 2026/05/14 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2600123 | Supplement | 2026/05/14 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2600122 | Supplement | 2026/05/14 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JXSS2600013 | Import | 2026/03/01 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXSS2600012 | Import | 2026/03/01 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXSS2400085 | Import | 2024/10/11 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXSS2400084 | Import | 2024/10/11 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXSS2400078 | Import | 2024/09/25 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXSS2400077 | Import | 2024/09/25 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXSS2400076 | Import | 2024/09/25 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXSS2400075 | Import | 2024/09/25 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/05/08
Supplement · 2
Abiraterone Acetate Tablets 4 records · Latest accepted 2026/05/07
Supplement · 2Import re-registration · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600244 | Supplement | 2026/05/07 | Janssen-Cilag International NV; Patheon Inc. | CDE ↗ |
| JYHZ2400132 | Import re-registration | 2024/05/23 | Janssen-Cilag International NV; Patheon Inc.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2400131 | Import re-registration | 2024/05/23 | Janssen-Cilag International NV; Patheon Inc.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2101230 | Supplement | 2021/07/02 | Janssen-Cilag International NV; Patheon Inc. | CDE ↗ |
No verified English name 13 records · Latest accepted 2026/04/23
Supplement · 9Import re-registration · 1Import · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600101 | Supplement | 2026/04/23 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSZ2600008 | Import re-registration | 2026/02/27 | Janssen-Cilag International NV; Cilag AG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JYSB2500172 | Supplement | 2025/07/24 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2500166 | Supplement | 2025/07/10 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JXSS2500061 | Import | 2025/05/14 | Janssen-Cilag International NV; Cilag AG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JYSB2500075 | Supplement | 2025/03/22 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2500022 | Supplement | 2025/02/07 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2300204 | Supplement | 2023/12/08 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2300140 | Supplement | 2023/08/18 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JXSL2300040 | Import | 2023/02/23 | Janssen-Cilag International NV; Johnson ＆Johnson(China)Investment Ltd. | CDE ↗ |
| JXSS2200013 | Import | 2022/04/15 | Janssen-Cilag International NV; Cilag AG; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYSB2200040 | Supplement | 2022/03/10 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2200015 | Supplement | 2022/01/30 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
Paliperidone Extend-release Tablets 27 records · Latest accepted 2026/04/18
Import re-registration · 9Supplement · 18
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600098 | Import re-registration | 2026/04/18 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2600097 | Import re-registration | 2026/04/18 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2600096 | Import re-registration | 2026/04/18 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2500249 | Supplement | 2025/05/01 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C. | CDE ↗ |
| JYHB2500248 | Supplement | 2025/05/01 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C. | CDE ↗ |
| JYHB2500247 | Supplement | 2025/05/01 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C. | CDE ↗ |
| JYHB2300620 | Supplement | 2023/11/01 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C. | CDE ↗ |
| JYHB2300619 | Supplement | 2023/11/01 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C. | CDE ↗ |
| JYHB2300618 | Supplement | 2023/11/01 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C. | CDE ↗ |
| JYHB2101590 | Supplement | 2021/12/14 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2101589 | Supplement | 2021/12/14 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2101588 | Supplement | 2021/12/14 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2101587 | Supplement | 2021/12/14 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2101586 | Supplement | 2021/12/14 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2101585 | Supplement | 2021/12/14 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2100550 | Import re-registration | 2021/05/26 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2100549 | Import re-registration | 2021/05/26 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2100548 | Import re-registration | 2021/05/26 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2100547 | Import re-registration | 2021/05/26 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2100546 | Import re-registration | 2021/05/26 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2100545 | Import re-registration | 2021/05/26 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2101019 | Supplement | 2021/04/01 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C. | CDE ↗ |
| JYHB2101018 | Supplement | 2021/04/01 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C. | CDE ↗ |
| JYHB2101017 | Supplement | 2021/04/01 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C. | CDE ↗ |
| JYHB2101016 | Supplement | 2021/04/01 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C. | CDE ↗ |
| JYHB2101015 | Supplement | 2021/04/01 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C. | CDE ↗ |
| JYHB2101014 | Supplement | 2021/04/01 | Janssen-Cilag International NV; Janssen Cilag Manufacturing L.L.C. | CDE ↗ |
Bedaquiline Fumarate Tablets 6 records · Latest accepted 2026/02/25
Import re-registration · 2Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600045 | Import re-registration | 2026/02/25 | Janssen-Cilag International NV; Recipharm Pharmaservices Private Limited; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2400511 | Supplement | 2024/09/28 | Janssen-Cilag International NV; Recipharm Pharmaservices Private Limited | CDE ↗ |
| JYHB2400028 | Supplement | 2024/01/19 | Janssen-Cilag International NV; Recipharm Pharmaservices Private Limited | CDE ↗ |
| JYHB2200608 | Supplement | 2022/11/08 | Janssen-Cilag International NV; Recipharm Pharmaservices Private Limited | CDE ↗ |
| JYHB2200508 | Supplement | 2022/09/15 | Janssen-Cilag International NV; Recipharm Pharmaservices Private Limited | CDE ↗ |
| JYHZ2100552 | Import re-registration | 2021/06/07 | Janssen-Cilag International NV; Recipharm Pharmaservices Private Limited; XIAN-JANSSEN PHARMACEUTICAL Ltd. | CDE ↗ |
Paliperidone Palmitate Injection 21 records · Latest accepted 2026/02/13
Import re-registration · 6Supplement · 15
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2600042 | Import re-registration | 2026/02/13 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2600041 | Import re-registration | 2026/02/13 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2600040 | Import re-registration | 2026/02/13 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2500682 | Supplement | 2025/12/10 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2500681 | Supplement | 2025/12/10 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2500680 | Supplement | 2025/12/10 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2500070 | Supplement | 2025/02/18 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2500069 | Supplement | 2025/02/18 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2500068 | Supplement | 2025/02/18 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2400478 | Supplement | 2024/09/04 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2400477 | Supplement | 2024/09/04 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2400476 | Supplement | 2024/09/04 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2300557 | Supplement | 2023/09/23 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2300556 | Supplement | 2023/09/23 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2300555 | Supplement | 2023/09/23 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHZ2100533 | Import re-registration | 2021/04/28 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V.; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2100532 | Import re-registration | 2021/04/28 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V.; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2100531 | Import re-registration | 2021/04/28 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V.; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2101047 | Supplement | 2021/04/15 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2101046 | Supplement | 2021/04/15 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2101045 | Supplement | 2021/04/15 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
Macitentan Tablets 1 records · Latest accepted 2026/01/31
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600075 | Supplement | 2026/01/31 | Janssen-Cilag International NV; Excella GmbH & Co.KG | CDE ↗ |
No verified English name 8 records · Latest accepted 2026/01/30
Import · 2Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2600030 | Import | 2026/01/30 | Janssen-Cilag International NV; Johnson & Johnson (China) Investment Ltd.？ | CDE ↗ |
| JYHB2500675 | Supplement | 2025/12/10 | Janssen-Cilag International NV; Renaissance Lakewood LLC | CDE ↗ |
| JYHB2500192 | Supplement | 2025/04/03 | Janssen-Cilag International NV; Renaissance Lakewood LLC; Janssen Cilag Manufacturing LLC | CDE ↗ |
| JYHB2500175 | Supplement | 2025/03/21 | Janssen-Cilag International NV; Renaissance Lakewood LLC | CDE ↗ |
| JYHB2400519 | Supplement | 2024/10/09 | Janssen-Cilag International NV; Renaissance Lakewood LLC | CDE ↗ |
| JYHB2400118 | Supplement | 2024/03/09 | Janssen-Cilag International NV; Renaissance Lakewood LLC | CDE ↗ |
| JYHB2300611 | Supplement | 2023/10/26 | Janssen-Cilag International NV; Renaissance Lakewood LLC | CDE ↗ |
| JXHS2200017 | Import | 2022/01/27 | Janssen-Cilag International NV; Renaissance Lakewood LLC; XIAN JANSSEN PHARMACEUTICAL LTD. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/11/19
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHS2500133 | Import | 2025/11/19 | Janssen-Cilag International NV; JANSSEN CILAG S.P.A.; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
Decitabine For Injection 3 records · Latest accepted 2025/09/19
Import re-registration · 1Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2500208 | Import re-registration | 2025/09/19 | Janssen-Cilag International NV; BSP Pharmaceuticals S. p. A.; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2200127 | Supplement | 2022/03/14 | Janssen-Cilag International NV; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JYHB2101305 | Supplement | 2021/08/11 | Janssen-Cilag International NV; BSP Pharmaceuticals S.p.A. | CDE ↗ |
No verified English name 12 records · Latest accepted 2025/08/28
Supplement · 12
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2500470 | Supplement | 2025/08/28 | Janssen-Cilag International NV; Janssen-Cilag SpA | CDE ↗ |
| JYHB2500469 | Supplement | 2025/08/28 | Janssen-Cilag International NV; Janssen-Cilag SpA | CDE ↗ |
| JYHB2500468 | Supplement | 2025/08/28 | Janssen-Cilag International NV; Janssen-Cilag SpA | CDE ↗ |
| JYHB2500368 | Supplement | 2025/07/16 | Janssen-Cilag International NV; Janssen-Cilag SpA | CDE ↗ |
| JYHB2500367 | Supplement | 2025/07/16 | Janssen-Cilag International NV; Janssen-Cilag SpA | CDE ↗ |
| JYHB2500366 | Supplement | 2025/07/16 | Janssen-Cilag International NV; Janssen-Cilag SpA | CDE ↗ |
| JYHB2500245 | Supplement | 2025/04/28 | Janssen-Cilag International NV; Janssen-Cilag SpA | CDE ↗ |
| JYHB2500244 | Supplement | 2025/04/28 | Janssen-Cilag International NV; Janssen-Cilag SpA | CDE ↗ |
| JYHB2500243 | Supplement | 2025/04/28 | Janssen-Cilag International NV; Janssen-Cilag SpA | CDE ↗ |
| JYHB2500079 | Supplement | 2025/02/17 | Janssen-Cilag International NV; Janssen-Cilag SpA | CDE ↗ |
| JYHB2500078 | Supplement | 2025/02/17 | Janssen-Cilag International NV; Janssen-Cilag SpA | CDE ↗ |
| JYHB2500077 | Supplement | 2025/02/17 | Janssen-Cilag International NV; Janssen-Cilag SpA | CDE ↗ |
No verified English name 4 records · Latest accepted 2025/08/22
Import · 2Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHS2500089 | Import | 2025/08/22 | Janssen-Cilag International NV; Patheon France; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXHS2500088 | Import | 2025/08/22 | Janssen-Cilag International NV; Patheon France; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2500233 | Supplement | 2025/04/23 | Janssen-Cilag International NV; Patheon France | CDE ↗ |
| JYHB2500232 | Supplement | 2025/04/23 | Janssen-Cilag International NV; Patheon France | CDE ↗ |
No verified English name 9 records · Latest accepted 2025/08/13
Supplement · 8Import re-registration · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2500182 | Supplement | 2025/08/13 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2500130 | Supplement | 2025/06/05 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2500096 | Supplement | 2025/04/07 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2400230 | Supplement | 2024/10/17 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSZ2400052 | Import re-registration | 2024/09/07 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYSB2300042 | Supplement | 2023/03/07 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2200100 | Supplement | 2022/06/20 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2200099 | Supplement | 2022/06/16 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2101094 | Supplement | 2021/07/27 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
No verified English name 5 records · Latest accepted 2025/07/25
Supplement · 2Import · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2500173 | Supplement | 2025/07/25 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2500119 | Supplement | 2025/05/22 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JXSS2400004 | Import | 2024/01/26 | Janssen-Cilag International NV; Cilag AG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXSS2300088 | Import | 2023/12/08 | Janssen-Cilag International NV; Cilag AG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXSS2300080 | Import | 2023/10/26 | Janssen-Cilag International NV; Cilag AG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/06/19
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHS2500070 | Import | 2025/06/19 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
No verified English name 6 records · Latest accepted 2025/04/28
Supplement · 4Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2500239 | Supplement | 2025/04/28 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYHB2500238 | Supplement | 2025/04/28 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYHB2400580 | Supplement | 2024/11/01 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYHB2400579 | Supplement | 2024/11/01 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JXHS2101067 | Import | 2021/11/04 | Janssen-Cilag International NV; Cilag AG; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXHS2101066 | Import | 2021/11/04 | Janssen-Cilag International NV; Cilag AG; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
No verified English name 18 records · Latest accepted 2025/02/18
Supplement · 14Import re-registration · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2500074 | Supplement | 2025/02/18 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2500073 | Supplement | 2025/02/18 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2500072 | Supplement | 2025/02/18 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2500071 | Supplement | 2025/02/18 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2500045 | Supplement | 2025/01/25 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2500044 | Supplement | 2025/01/25 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2500043 | Supplement | 2025/01/25 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2500042 | Supplement | 2025/01/25 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHZ2300007 | Import re-registration | 2023/01/05 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V.; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2300006 | Import re-registration | 2023/01/05 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V.; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2300005 | Import re-registration | 2023/01/05 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V.; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHZ2300004 | Import re-registration | 2023/01/05 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V.; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| JYHB2200493 | Supplement | 2022/09/09 | Janssen-Cilag International NV; Janssen Pharmaceutica NV | CDE ↗ |
| JYHB2200492 | Supplement | 2022/09/09 | Janssen-Cilag International NV; Janssen Pharmaceutica NV | CDE ↗ |
| JYHB2101024 | Supplement | 2021/04/10 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2101023 | Supplement | 2021/04/10 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2101022 | Supplement | 2021/04/10 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
| JYHB2101021 | Supplement | 2021/04/10 | Janssen-Cilag International NV; Janssen Pharmaceutica N.V. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/02/18
Supplement · 2
No verified English name 2 records · Latest accepted 2025/01/01
Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHS2400123 | Import | 2025/01/01 | Janssen-Cilag International NV; Penn Pharmaceutical Services Limited; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| JXHS2400122 | Import | 2025/01/01 | Janssen-Cilag International NV; Penn Pharmaceutical Services Limited; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2023/10/19
Import · 2
No verified English name 2 records · Latest accepted 2023/04/18
Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHS2300035 | Import | 2023/04/18 | Janssen-Cilag International NV; PATHEON FRANCE; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| JXHS2300034 | Import | 2023/04/18 | Janssen-Cilag International NV; PATHEON FRANCE; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/09/07
Supplement · 1Import · 1
No verified English name 2 records · Latest accepted 2022/09/07
Supplement · 1Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHB2200126 | Supplement | 2022/09/07 | Janssen-Cilag International NV; Patheon Pharmaceuticals Inc.; Janssen-Cilag SpA | CDE ↗ |
| JXHL2101140 | Import | 2021/07/26 | Janssen-Cilag International NV; Johnson & Johnson (China) Investment Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/08/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSB2200104 | Supplement | 2022/08/29 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
No verified English name 6 records · Latest accepted 2021/10/11
Supplement · 4Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2101146 | Supplement | 2021/10/11 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2101145 | Supplement | 2021/10/11 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2101130 | Supplement | 2021/09/13 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JYSB2101129 | Supplement | 2021/09/13 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JXSS2100016 | Import | 2021/02/19 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| JXSS2100015 | Import | 2021/02/19 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
Changes in the last 90 days
22 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 21 applicationsNo longer listed under review: 1 application
- 2026/11/06No longer listed under review
Miglustat Capsules
JYHZ2600139
Fact date: 2026/11/06 · Site observation date: 2026/11/06
Accepted: 2026/06/08
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/05Accepted
No verified English name
JYSB2600311
Fact date: 2026/11/05 · Site observation date: 2026/11/06
View source ↗ - 2026/11/05Accepted
No verified English name
JYSB2600310
Fact date: 2026/11/05 · Site observation date: 2026/11/06
View source ↗ - 2026/10/23Accepted
No verified English name
JYSB2600292
Fact date: 2026/10/23 · Site observation date: 2026/10/24
View source ↗ - 2026/10/21Accepted
Canagliflozin Tablets
JYHB2600564
Fact date: 2026/10/21 · Site observation date: 2026/10/22
View source ↗ - 2026/10/21Accepted
Canagliflozin Tablets
JYHB2600563
Fact date: 2026/10/21 · Site observation date: 2026/10/22
View source ↗ - 2026/10/21Accepted
Ibrutinib Capsules
JYHB2600561
Fact date: 2026/10/21 · Site observation date: 2026/10/22
View source ↗ - 2026/10/19Accepted
No verified English name
JXSS2600097
Fact date: 2026/10/19 · Site observation date: 2026/10/22
View source ↗ - 2026/10/19Accepted
No verified English name
JXSS2600096
Fact date: 2026/10/19 · Site observation date: 2026/10/22
View source ↗ - 2026/10/16Accepted
Bortezomib For Injection
JYHZ2600266
Fact date: 2026/10/16 · Site observation date: 2026/10/22
View source ↗ - 2026/09/22Accepted
No verified English name
JYSB2600261
Fact date: 2026/09/22 · Site observation date: 2026/10/22
View source ↗ - 2026/09/22Accepted
Apalutamide Tablets
JYHB2600530
Fact date: 2026/09/22 · Site observation date: 2026/10/21
View source ↗ - 2026/09/20Accepted
Selexipag Tablets
JXHS2600113
Fact date: 2026/09/20 · Site observation date: 2026/10/22
View source ↗ - 2026/09/20Accepted
Selexipag Tablets
JXHS2600112
Fact date: 2026/09/20 · Site observation date: 2026/10/22
View source ↗ - 2026/09/20Accepted
Selexipag Tablets
JXHS2600111
Fact date: 2026/09/20 · Site observation date: 2026/10/22
View source ↗ - 2026/09/20Accepted
Selexipag Tablets
JXHS2600110
Fact date: 2026/09/20 · Site observation date: 2026/10/22
View source ↗ - 2026/09/20Accepted
Selexipag Tablets
JXHS2600109
Fact date: 2026/09/20 · Site observation date: 2026/10/22
View source ↗ - 2026/09/20Accepted
Selexipag Tablets
JXHS2600108
Fact date: 2026/09/20 · Site observation date: 2026/10/22
View source ↗ - 2026/09/20Accepted
Selexipag Tablets
JXHS2600107
Fact date: 2026/09/20 · Site observation date: 2026/10/22
View source ↗ - 2026/09/20Accepted
Selexipag Tablets
JXHS2600106
Fact date: 2026/09/20 · Site observation date: 2026/10/22
View source ↗ - 2026/08/17Accepted
Selexipag Tablets
JXHS2600092
Fact date: 2026/08/17 · Site observation date: 2026/10/22
View source ↗ - 2026/08/17Accepted
Selexipag Tablets
JXHS2600091
Fact date: 2026/08/17 · Site observation date: 2026/10/22
View source ↗
Under review
36 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | JYSB2600311 | Supplement | 2026/11/05 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| No verified English name | JYSB2600310 | Supplement | 2026/11/05 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| No verified English name | JYSB2600292 | Supplement | 2026/10/23 | Janssen-Cilag International NV; Cilag AG; Patheon Italia S.p.A. | CDE ↗ |
| Canagliflozin Tablets | JYHB2600564 | Supplement | 2026/10/21 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| Canagliflozin Tablets | JYHB2600563 | Supplement | 2026/10/21 | Janssen-Cilag International NV; Janssen-Cilag S.p.A. | CDE ↗ |
| Ibrutinib Capsules | JYHB2600561 | Supplement | 2026/10/21 | Janssen-Cilag International NV; Catalent CTS LLC; Cilag AG | CDE ↗ |
| No verified English name | JXSS2600097 | Import | 2026/10/19 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| No verified English name | JXSS2600096 | Import | 2026/10/19 | Janssen-Cilag International NV; Patheon Manufacturing Services LLC; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| Bortezomib For Injection | JYHZ2600266 | Import re-registration | 2026/10/16 | Janssen-Cilag International NV; BSP Pharmaceuticals S.p.A.; XIAN JANSSEN PHARMACEUTICAL Ltd. | CDE ↗ |
| No verified English name | JYSB2600261 | Supplement | 2026/09/22 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| Apalutamide Tablets | JYHB2600530 | Supplement | 2026/09/22 | Janssen-Cilag International NV; Janssen Ortho LLC; Catalent Pharma Solutions LLC | CDE ↗ |
| Selexipag Tablets | JXHS2600113 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| Selexipag Tablets | JXHS2600112 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| Selexipag Tablets | JXHS2600111 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| Selexipag Tablets | JXHS2600110 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| Selexipag Tablets | JXHS2600109 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| Selexipag Tablets | JXHS2600108 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| Selexipag Tablets | JXHS2600107 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| Selexipag Tablets | JXHS2600106 | Import | 2026/09/20 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| Selexipag Tablets | JXHS2600092 | Import | 2026/08/17 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| Selexipag Tablets | JXHS2600091 | Import | 2026/08/17 | Janssen-Cilag International NV; Excella GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| Ibrutinib Capsules | JYHZ2600188 | Import re-registration | 2026/08/05 | Janssen-Cilag International NV; Catalent CTS LLC; Cilag AG; Xian-Janssen Pharmaceutical Ltd. | CDE ↗ |
| Apalutamide Tablets | JXHS2600061 | Import | 2026/06/10 | Janssen-Cilag International NV; Janssen Ortho LLC; Catalent Pharma Solutions LLC; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| No verified English name | JXSS2600045 | Import | 2026/06/01 | Janssen-Cilag International NV; Vetter Pharma-Fertigung GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| No verified English name | JXSS2600044 | Import | 2026/06/01 | Janssen-Cilag International NV; Vetter Pharma-Fertigung GmbH & Co. KG; Johnson & Johnson Pharmaceutical Ltd. | CDE ↗ |
| No verified English name | JYSB2600125 | Supplement | 2026/05/14 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| No verified English name | JYSB2600124 | Supplement | 2026/05/14 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| No verified English name | JYSB2600123 | Supplement | 2026/05/14 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| No verified English name | JYSB2600122 | Supplement | 2026/05/14 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| Abiraterone Acetate Tablets | JYHB2600244 | Supplement | 2026/05/07 | Janssen-Cilag International NV; Patheon Inc. | CDE ↗ |
| No verified English name | JXSS2600037 | Import | 2026/04/16 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| No verified English name | JXSS2600036 | Import | 2026/04/16 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| No verified English name | JXSS2600013 | Import | 2026/03/01 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| No verified English name | JXSS2600012 | Import | 2026/03/01 | Janssen-Cilag International NV; Cilag AG; Xian Janssen Pharmaceutical Ltd. | CDE ↗ |
| No verified English name | JYSB2500130 | Supplement | 2025/06/05 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
| No verified English name | JYSB2500126 | Supplement | 2025/05/31 | Janssen-Cilag International NV; Cilag AG | CDE ↗ |
Catalogue holder records
11 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Apalutamide Tablets | Janssen-Cilag International NV | Janssen Ortho,LLC；Catalent Pharma Solutions, LLC | 国药准字HJ20200029 | 2019/09/05 | Imported originator drug | CDE ↗ |
| No verified English name | Janssen-Cilag International NV | Janssen Pharmaceutica N.V. | H20180023 | 2018/05/17 | Imported originator drug | CDE ↗ |
| No verified English name | Janssen-Cilag International NV | Janssen Pharmaceutica N.V. | H20180020 | 2018/05/17 | Imported originator drug | CDE ↗ |
| No verified English name | Janssen-Cilag International NV | Janssen Pharmaceutica N.V. | H20180021 | 2018/05/17 | Imported originator drug | CDE ↗ |
| No verified English name | Janssen-Cilag International NV | Janssen Pharmaceutica N.V. | H20180022 | 2018/05/17 | Imported originator drug | CDE ↗ |
| Canagliflozin Tablets | Janssen-Cilag International NV | Janssen Ortho, LLC | H20170374 | 2017/09/29 | Imported originator drug | CDE ↗ |
| Canagliflozin Tablets | Janssen-Cilag International NV | Janssen Ortho, LLC | H20170375 | 2017/09/29 | Imported originator drug | CDE ↗ |
| Simeprevir Capsules | Janssen-Cilag International NV | Janssen-Cilag S.p.A. | H20170349 | 2017/08/24 | Imported originator drug | CDE ↗ |
| Paliperidone Extend-release Tablets | Janssen-Cilag International NV | Janssen Cilag Manufacturing L.L.C. | H20160550 | 2008/09/28 | Imported originator drug | CDE ↗ |
| Paliperidone Extend-release Tablets | Janssen-Cilag International NV | Janssen Cilag Manufacturing L.L.C. | H20160549 | 2008/09/28 | Imported originator drug | CDE ↗ |
| Decitabine For Injection | Janssen-Cilag International NV | Pharmachemie B.V. | H20181217 | 2008/09/28 | Imported originator drug | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
28 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | JTH2600141 | Not stated by source | 2026/07/14 | Janssen-Cilag SpA; Janssen-Cilag International NV; Qiang Sheng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2600140 | Not stated by source | 2026/07/14 | Janssen-Cilag SpA; Janssen-Cilag International NV; Qiang Sheng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2600108 | Not stated by source | 2026/06/30 | Lonza AG; Janssen-Cilag International NV; Qiang Sheng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2500156 | Not stated by source | 2025/10/24 | JANSSEN CILAG S.P.A.; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2400066 | Not stated by source | 2024/08/02 | Vetter Pharma-Fertigung GmbH & Co. KG; Janssen-Cilag International NV; Qiang Sheng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2400065 | Not stated by source | 2024/08/02 | Vetter Pharma-Fertigung GmbH & Co. KG; Janssen-Cilag International NV; Qiang Sheng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2400126 | Not stated by source | 2024/08/02 | Excella GmbH & Co KG; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2400125 | Not stated by source | 2024/08/02 | Excella GmbH & Co KG; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2400023 | Not stated by source | 2024/03/15 | Cilag AG; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2400022 | Not stated by source | 2024/03/15 | Cilag AG; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2400021 | Not stated by source | 2024/03/15 | Janssen Sciences Ireland UC; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2300083 | Not stated by source | 2023/12/20 | Cilag AG; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2300082 | Not stated by source | 2023/12/20 | Janssen Sciences Ireland UC; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2300058 | Not stated by source | 2023/10/30 | Patheon Manufacturing Services LLC; Janssen-Cilag International NV; Qiang Sheng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2300057 | Not stated by source | 2023/10/30 | Patheon Manufacturing Services LLC; Janssen-Cilag International NV; Qiang Sheng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2300056 | Not stated by source | 2023/10/30 | Janssen Sciences Ireland UC (JSI); Janssen-Cilag International NV; Qiang Sheng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2300238 | Not stated by source | 2023/10/10 | Janssen-Cilag SpA; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2300129 | Not stated by source | 2023/05/22 | Janssen Pharmaceutica N.V.; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2300128 | Not stated by source | 2023/05/22 | Janssen Pharmaceutica N.V.; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2300127 | Not stated by source | 2023/05/22 | Janssen Pharmaceutica N.V.; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2200109 | Not stated by source | 2022/12/28 | Patheon Manufacturing Services LLC; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2200108 | Not stated by source | 2022/12/28 | Patheon Manufacturing Services LLC; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2200107 | Not stated by source | 2022/12/28 | Janssen Sciences Ireland UC (JSI); Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2200087 | Not stated by source | 2022/10/14 | Cilag AG; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2200086 | Not stated by source | 2022/10/14 | Janssen Sciences Ireland UC (JSI); Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2100549 | Not stated by source | 2021/12/23 | Janssen Sciences Ireland UC (JSI); Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Miglustat Capsules | JTH2100700 | Not stated by source | 2021/11/25 | Almac Pharma Services Limited; Janssen-Cilag International NV; Ai Ke Tai Long Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2100541 | Not stated by source | 2021/11/10 | Cilag AG; Janssen-Cilag International NV; Xian Yang Sen Pharmaceutical Co., Ltd. romanized | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.